TONIX PHARMACEUTICALS HOLDING CORP. (TNXP)

Import this data to Google Sheets with:

=jivedata("TNXP","financials")

Full statements spill as a table. For one cell: =jivedata("TNXP","Revenue") or =jivedata("TNXP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

TONIX PHARMACEUTICALS HOLDING CORP.

TNXP • CIK 0001430306

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$7,768	$10,094	$13,107	$29,102
Operating Income (Loss)	$-118,380	$-136,701	$-125,703	$-165,425
GovernmentAssistanceNonoperatingIncome	—	$2,594	$3,012	$1,653
Gain (Loss) on Derivative Instruments, Net, Pretax	—	$6,150	$6,150	$6,150
Gain (Loss) on Extinguishment of Debt	—	—	$-2,092	$0
Investment Income, Interest	$1,722	—	$4,146	$5,098
InterestExpenseNonoperating	—	—	$89	$89
Other Nonoperating Income (Expense)	—	$-2,079	$-3,295	$-1,158
Net Income (Loss) Available to Common Stockholders, Basic	$-116,658	$-130,036	$-124,021	$-159,666
Weighted Average Number of Shares Outstanding, Basic	17,039,309	736,339	8,511,318	17,059,475
Cost of Revenue	$4,741	$7,765	$6,640	$4,706
Research and Development Expense	$86,655	$39,972	$44,486	$63,860
Selling, General and Administrative Expense	$34,752	$40,101	$87,684	$125,961
Asset Impairment Charges	—	$58,957	$58,957	$58,957
Costs and Expenses	$126,148	$146,795	$138,810	$194,527

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$24,948	$98,776	$207,637	$176,232
Accounts Receivable, after Allowance for Credit Loss, Current	—	$3,683	$6,271	$11,805
Property, Plant and Equipment, Net	$94,028	$42,252	$44,456	$44,760
FIFO Inventory Amount	—	—	$6,013	$4,678
Intangible Assets, Net (Excluding Goodwill)	$9,743	$120	$120	$120
Prepaid Expense and Other Assets, Current	$9,181	$8,135	$8,955	$10,717
Operating Lease, Right-of-Use Asset	$824	$565	$1,544	$1,346
Assets, Current	$47,768	$119,002	$228,876	$203,432
Other Assets, Noncurrent	$1,129	$951	$2,175	$4,550
Assets	$154,457	$162,890	$277,171	$254,088
Long-term Debt, Excluding Current Maturities	$6,561	$4,667	$4,667	$4,667
Operating Lease, Liability, Noncurrent	$632	$358	$1,184	$1,022
Liabilities	$48,932	$23,332	$32,021	$31,807
Accounts Payable, Current	$3,782	$4,546	$8,114	$9,051
Accounts Payable and Other Accrued Liabilities, Current	$12,482	$10,667	$22,598	$21,484
Long-term Debt, Current Maturities	$2,350	$2,820	$2,820	$2,820
Operating Lease, Liability, Current	$270	$274	$125	$250
Liabilities, Current	$18,884	$18,307	$30,837	$30,785
Common Stock, Value, Issued	$59	$4	$13	$17
Additional Paid in Capital, Common Stock	$706,356	$870,503	$1,100,141	$1,158,073
Retained Earnings (Accumulated Deficit)	$-600,658	$-730,694	$-854,715	$-935,461
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-232	$-255	$-289	$-348
Stockholders' Equity Attributable to Parent	$105,525	$139,558	$245,150	$222,281
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	—	0	0	0
Common Stock, Shares Authorized	160,000,000	1,000,000,000	1,000,000,000	1,000,000,000
Common Stock, Shares, Issued	58,614,593	4,385,929	12,788,069	16,792,317
Common Stock, Capital Shares Reserved for Future Issuance	66,329	21	5,883	5,883
Restricted Cash	$901	$904	$2,170	$387
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$25,849	$99,680	$209,807	$176,619
Contract with Customer, Asset, after Allowance for Credit Loss, Current	$4,590	$881	$3,485	$3,247
Prepaid Supplies	$508	$508	$1,000	$1,000
Nontrade Receivables	—	$953	$953	$908
Prepaid Insurance	$143	$1,392	$1,650	$722
Prepaid Taxes	—	—	$566	$262
Other Prepaid Expense, Current	—	—	$1,591	$5,265
Contract with Customer, Liability, Current	$2,980	$1,816	$3,425	$3,816
Customer Refund Liability, Current	$743	$3,658	$7,909	$10,226

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-116,658	$-130,036	$-124,021	$-159,666
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-65	$4	$-31	$-76
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-94,621	$73,831	$110,127	$50,383
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$25,849	$99,680	$209,807	$263,196
Depreciation, Depletion and Amortization	$4,291	$3,421	$1,925	$2,123
Payments to Acquire Notes Receivable	—	—	$2,012	$2,012
Financing Receivable, Credit Loss, Expense (Reversal)	—	—	$31	$31
Proceeds from Collection of Notes Receivable	—	—	$853	$853
Asset Impairment Charges	—	$58,957	$58,957	$58,957
Payments to Acquire Property, Plant, and Equipment	$7,895	$120	$3,369	$5,115
Share-based Payment Arrangement, Noncash Expense	$9,275	$4,778	$6,017	$7,938
Net Cash Provided by (Used in) Investing Activities	$-29,070	$-120	$-4,528	$-4,262
Fair Value Adjustment of Warrants	$283	$-6,150	$-6,150	$-6,150
Gain (Loss) on Extinguishment of Debt	—	—	$-2,092	$0
Inventory Write-down	—	$1,490	$669	$669
Amortization of Debt Discount (Premium)	—	$840	$65	$65
Amortization of Debt Issuance Costs	—	—	$1,837	$1,837
Increase (Decrease) in Accounts Receivable	—	$3,683	$2,619	$9,516
Payments of Merger Related Costs, Financing Activities	—	$3,000	$3,000	$3,000
Increase (Decrease) in Inventories	$-61	$-3,741	$-1,726	$-1,050
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$29	$27	$27	—
Increase (Decrease) in Prepaid Expense and Other Assets	$-1,573	$-3,613	$3,161	$4,441
Repayments of Long-term Debt	—	$2,350	$9,650	$9,650
Increase (Decrease) in Accounts Payable, Trade	$-3,490	$927	$2,994	$1,220
Proceeds from Issuance of Common Stock	$18,939	$140,195	$237,940	$215,430
IncreaseDecreaseInOperatingLeaseLiability	$35	$-13	$-303	$-131
Payments for Repurchase of Common Stock	$13,965	$13,965	$13,760	$13,760
Increase (Decrease) in Other Accrued Liabilities	$1,786	$1,190	$11,745	$11,020
Net Cash Provided by (Used in) Financing Activities	$36,517	$134,872	$214,530	$207,714
Net Cash Provided by (Used in) Operating Activities	$-102,003	$-60,925	$-99,844	$-152,993
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	$1,234	$89	$89
Capital Expenditures Incurred but Not yet Paid	—	$106	$865	$402
Payments of Stock Issuance Costs	—	—	$8,750	$7,718

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("TNXP","financials")

Full statements spill as a table. For one cell: =jivedata("TNXP","Revenue") or =jivedata("TNXP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.